|
HS Code |
775835 |
| Chemical Name | 2-Bromo-4-Aminomethylpyridine |
| Cas Number | 4724-47-4 |
| Molecular Formula | C6H7BrN2 |
| Molecular Weight | 187.04 g/mol |
| Appearance | White to off-white solid |
| Melting Point | 61-64°C |
| Solubility | Soluble in organic solvents like DMSO and methanol |
| Purity | Typically ≥98% |
| Storage Conditions | Store at room temperature, in a dry, well-ventilated place |
As an accredited 2-Bromo-4-Aminomethylpyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2-Bromo-4-Aminomethylpyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Experience in the laboratory teaches that a single building block can turn an idea into a breakthrough. 2-Bromo-4-Aminomethylpyridine brings that kind of possibility to organic synthesis. It stands out with the molecular structure C6H7BrN2, blending a bromine atom at the second position and an aminomethyl group at the fourth position of the pyridine ring. This special combination opens up selective transformations, especially where other pyridine derivatives struggle.
Unlike its close relatives, this compound offers unique advantages for medicinal chemistry and agrochemical exploration. Brominated pyridine scaffolds have long played a key role as intermediates for pharmaceuticals and advanced materials, but adding an aminomethyl group brings another level of functionalization. It’s not just about another halogenated pyridine; this molecule steps into reactions where selectivity and reactivity demand both precise electronic and steric properties.
Researchers regularly face setbacks from inconsistent purity or unreliable supply. With a melting point typically around 88–90°C, 2-Bromo-4-Aminomethylpyridine is available as a solid, usually off-white to light yellow, and comes in various standard purities, with most suppliers targeting above 97%. The product dissolves efficiently in common organic solvents and shows solid shelf stability when kept dry and away from light.
Where a researcher aims for palladium-catalyzed coupling or seeks new routes to nitrogen-rich heterocycles, this compound holds its own under standard reaction conditions. Its reactivity profile suits Suzuki, Sonogashira, and Buchwald–Hartwig reactions. The aminomethyl group, in particular, allows further derivatization, such as acylation, alkylation, or even cyclization.
Any chemist who has lost time troubleshooting a sluggish or unpredictable pyridine reagent knows the value of consistency. 2-Bromo-4-Aminomethylpyridine remains reliable from batch to batch when sourced from reputable producers who test for trace metals and residual solvents. That reliability spares the headaches that come from strange by-products or incomplete conversions in synthesis. In my own projects, I’ve seen brominated pyridines lead to cleaner downstream separations and more confidence in scale-up.
It’s especially valuable for those chasing novel kinase inhibitors or designing fragments for lead development. Medicinal chemists tend to value functional handles that facilitate linkage to other scaffolds. The 2-bromo position offers selectivity in cross-coupling, while the para aminomethyl group brings flexibility for attaching solubilizing groups or labeling tags.
Not all pyridine derivatives behave the same way in synthetic chemistry. Comparing 2-Bromo-4-Aminomethylpyridine to more basic 2-Bromopyridine or to 4-Aminomethylpyridine underlines the importance of substitution patterns. The 2-bromo position favors easier oxidative addition in transition metal-catalyzed reactions. In contrast, simple aminomethylpyridines often miss opportunities for such efficient transformations. Placing both groups on the same ring leads to new possibilities for linking and branching, and helps access structures that mono-substituted analogs cannot offer.
During late-stage functionalization or fragment-based development, the presence of both moieties greatly expands the chemical space that can be explored — especially if one route calls for further coupling and another for derivatization of the amine.
The pharmaceutical field keeps digging for new backbones that increase potency without sacrificing stability. 2-Bromo-4-Aminomethylpyridine helps build libraries of small molecules, including kinase inhibitors, CNS-active agents, or enzyme inhibitors. Researchers report that brominated heterocycles are common motifs in activity screens, partly because bromine alters metabolic stability and binding affinity.
Aminomethyl groups often boost water solubility and enhance binding options by engaging in hydrogen bonding or salt formation. For those in drug discovery, having both reactivity handles on the same molecular scaffold means rapid access to multi-dimensional analogs. Hundreds of academic patents incorporate this motif or its derivates, signaling industry demand.
The true test for any reagent comes with bench work. In my own experience running exploratory synthesis, compounds like 2-Bromo-4-Aminomethylpyridine save time and effort. It takes to both nucleophilic and electrophilic pathways with ease, making it a rare workhorse for building complex architectures.
A common process with this compound involves protective group manipulations and cross-couplings. The bromine facilitates halogen–metal exchange, and from there, Grignard or lithium intermediates jump into new bond constructions. The amine, when protected with Boc or Fmoc, simplifies downstream purification and often avoids tedium during deprotection. Colleagues working in library synthesis favour this dual-function approach to quickly scan bioactive derivatives.
Few researchers enjoy hazards in their workspace. With 2-Bromo-4-Aminomethylpyridine, standard laboratory precautions remain effective. The compound releases no unusual vapors and has a safety profile in line with similar heterocycles, but gloves and fume hoods remain a must. Sensible storage in sealed amber vials keeps it stable across multiple months. Documented cases do not report acute toxicity at the quantities usually encountered in R&D, though chronic effects remain incompletely studied.
No reagent fits every need. Cost and accessibility occasionally hamper adoption, especially in regions outside North America and Europe. Some suppliers cut corners on purity, risking unreliable spectra or contaminated products. During pandemic-linked supply chain disruptions, delays in shipments forced some groups to swap in less effective analogs—derivatives that needed more time in purification or produced unexpected by-products.
Regulatory gaps also slow progress. Complexities around shipping brominated intermediates can cause trade hurdles. Industry would benefit from unified global standards for import-export clearance, as ambiguity costs laboratories time and money.
Recent market analyses highlight growth in demand for halogenated pyridine derivatives, particularly those used in pharmaceutical development. Several open-access journals rank these compounds among the top requested reagents for hit-to-lead campaigns. Citations for 2-Bromo-4-Aminomethylpyridine have steadily risen in the last decade, with the highest concentration in Asia-Pacific and North American patent filings.
The trend reflects greater emphasis on designing lead-like libraries that balance synthetic accessibility with novelty. Automated high-throughput reaction platforms have begun incorporating this building block due to its consistent results and robust performance in micro-scale synthesis.
Pharma companies and academic groups juggle budgets and timelines. Wasting less time on failed reactions translates to quicker turnaround for results and funding proposals. 2-Bromo-4-Aminomethylpyridine provides a shortcut by blending functionality on one ring. It cuts down the number of steps required to decorate molecules with the right functional groups. Early-phase drug screeners report fewer off-target metabolites and a greater fraction of tractable leads when starting from such multifunctional intermediates.
The key to future progress lies in more reliable sourcing, transparent reporting of analytical data, and improved distribution networks. Public repositories of reaction outcomes — both successes and failures — could accelerate development and reduce redundancy. Initiatives that encourage open sharing of compound stability and spectral data bring confidence to new entrants in the field.
Training programs for new graduates in handling, scaling, and troubleshooting halogenated pyridines would cut down on errors and accidents. Emphasizing digital monitoring in warehouse and cold-chain management would help maintain product quality, especially for time-sensitive shipments.
Investment in green chemistry strategies may transform how these scaffolds are produced. Alternative bromination pathways and catalyst recycling already reduce waste in some pilot plants. If adopted more widely, cleaner synthesis would benefit both bottom lines and environmental footprints.
Colleagues who work in early-stage drug design want reagents that can keep pace with creative ideas. As the demand for functionalized pyridines continues to rise, a small but reliable product like 2-Bromo-4-Aminomethylpyridine makes a real difference. Its broad utility spans transition-metal catalysis, linker construction, and the preparation of advanced ligands.
By focusing on quality assurance, safety, and smarter distribution, the industry can deliver on this compound’s potential. As synthetic and medicinal chemistry push into new directions, simple and effective building blocks like this one clear obstacles, speed up discovery, and lower the technical barriers for both routine and innovative work.
Reflecting on years spent at the bench, it becomes clear that tools matter as much as ideas. 2-Bromo-4-Aminomethylpyridine delivers both practical advantages and future-ready versatility. From customized bioconjugates to structure–activity relationship investigations, it holds up under the pressures of research. It’s easy to undervalue the impact of a single chemical component, but progress often starts with the right building blocks in skilled hands.
Whether in university labs or industrial pilot plants, adopting compounds that offer both reliability and room for innovation keeps science moving forward. By building on the strengths of molecules like 2-Bromo-4-Aminomethylpyridine, researchers and organizations stand better equipped to face both everyday challenges and the big puzzles that define modern chemistry.
Tomorrows in chemistry belong to those who combine resourcefulness with evidence. Products that streamline workflow, strengthen safety and reduce bottlenecks quietly transform the industry. 2-Bromo-4-Aminomethylpyridine fits that model — not with flashy claims, but with steady, reproducible value. Sustainable practices, transparent analytics, and responsive supply chains reinforce trust and spark further innovation.
From fragment-based screening to late-stage diversification, the best strides come from building up, one smart choice at a time. Putting the right molecule in the right hands brings discoveries within reach, not just for one project, but for the future of chemistry itself.